Status:
COMPLETED
Generation and Validation of Predictive Models for Localized Prostate Cancer Treated With External Radiotherapy.
Lead Sponsor:
Consorci Sanitari de Terrassa
Conditions:
Predictive Cancer Model
Localized Prostate Carcinoma
Eligibility:
MALE
18-95 years
Brief Summary
The generation of predictive models in radiotherapy has seen a significant increase. In 2017, Raymond published the largest systematic review of predictive prognostic models for biochemical relapse (B...
Detailed Description
The general objective of the study is to develop a predictive model for oncological outcomes and bladder and rectal toxicities based on the analysis of patients with localized prostate cancer who have...
Eligibility Criteria
Inclusion
- Histological confirmation of prostate adenocarcinoma through biopsy. ECOG (Eastern Cooperative Oncology Group) performance status score \<2. Signed informed consent form.
Exclusion
- Affected lymph nodes or confirmed metastatic disease (bone or lymph node) in prostate cancer based on imaging studies (CT scan, bone scan, MRI).
- Anticoagulant therapy, individual evaluation of antiplatelet therapy. Prior pelvic radiotherapy. Prior surgery for prostate cancer. Personal history of Crohn's disease or ulcerative colitis.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT06092918
Start Date
January 1 2013
End Date
January 1 2023
Last Update
October 23 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.